Recommendation
- https://www.mayoclinic.org/diseases-conditions/nonalcoholic-fatty-liver-disease/symptoms-causes/syc-20354567Mayo ClinicNonalcoholic fatty liver disease - Symptoms and causes - Mayo ClinicApr 4, 2024 ... NAFLD ranges in severity from hepatic steatosis, called fatty liver, to a more severe form of disease called nonalcoholic steatohepatitis (NASH) ...
- https://www.niddk.nih.gov/health-information/liver-disease/nafld-nashNational Institute of Diabetes and Digestive and Kidney DiseasesNonalcoholic Fatty Liver Disease (NAFLD) & NASH - NIDDKDefinition & Facts. Nonalcoholic fatty liver disease (NAFLD) is a condition in which fat builds up in your liver. Nonalcoholic fatty liver (NAFL) and ...
- https://www.nature.com/articles/nrgastro.2017.109Global burden of NAFLD and NASH: trends, predictions, risk factors ...Sep 20, 2017 ... NAFLD is one of the most important causes of liver disease worldwide and will probably emerge as the leading cause of end-stage liver disease in the coming ...
- https://www.niddk.nih.gov/health-information/liver-disease/nafld-nash/definition-factsNational Institute of Diabetes and Digestive and Kidney DiseasesDefinition & Facts of NAFLD & NASH - NIDDKNAFLD (also referred to as metabolic dysfunction-associated steatotic liver disease, or MASLD), is a condition in which excess fat builds up in your liver.
- https://pubmed.ncbi.nlm.nih.gov/31279902/PubMedThe global epidemiology of NAFLD and NASH in patients with type ...This study provides the global prevalence rates for NAFLD, NASH, and advanced fibrosis in patients with T2DM.
- https://www.sciencedirect.com/science/article/pii/S0168827817322821Genetics and epigenetics of NAFLD and NASH: Clinical impact ...The premise for this review is to discuss the status of research into important genetic and epigenetic modifiers of NAFLD progression.
- https://pubmed.ncbi.nlm.nih.gov/29844588/PubMedNoninvasive biomarkers in NAFLD and NASH - current progress ...Nonalcoholic fatty liver disease (NAFLD) affects 25% of the global adult population and is the most common chronic liver disease worldwide.
- https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8953348/PubMed Central (PMC)Emerging Role of Nuclear Receptors for the Treatment of NAFLD ...... NAFLD and NASH. The TZDs rosiglitazone and pioglitazone were tested in ... Abbreviations. NAFLD, Non-Alcoholic Fatty Liver Disease; NASH, Non-Alcoholic ...
- https://pmc.ncbi.nlm.nih.gov/articles/PMC6365925/PubMed Central (PMC)The role of the microbiome in NAFLD and NASH - PMCIn this review, we will explore the impact of gut microbiota and microbiota‐derived compounds on the development and progression of NAFLD and NASH.
- https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE126848GSE126848Non-alcoholic fatty liver disease (NAFLD) ... The hepatic molecular events underlying the development of NAFLD and transition to NASH are poorly understood.
Recommend
Copyright © 2024 Clever search. All rights reserved